European Journal of Obstetrics & Gynecology and Reproductive Biology 184 (2015) 38–42
Contents lists available at ScienceDirect
European Journal of Obstetrics & Gynecology and Reproductive Biology journal homepage: www.elsevier.com/locate/ejogrb
Borderline ovarian tumor in women aged 65 years: impact on recurrence and survival Taejong Song a, Yoo-Young Lee b, Chel Hun Choi b, Tae-Joong Kim b, Jeong-Won Lee b, Duk-Soo Bae b, Byoung-Gie Kim b,* a
Department of Obstetrics & Gynecology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea Department of Obstetrics & Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-Dong, Gangnam-gu, Seoul 135710, Republic of Korea b
A R T I C L E I N F O
A B S T R A C T
Article history: Received 3 March 2014 Received in revised form 6 August 2014 Accepted 3 October 2014
Objective: Borderline ovarian tumor (BOT) is uncommon in women with advanced age. The authors investigated the characteristics and treatment outcomes of women with BOT 65 years of age. Study Design: A hospital-based tumor registry was used to identify retrospectively patients with BOT who were treated between 1996 and 2011. Patients were divided into two cohorts: women aged
Borderline ovarian tumor in women aged ≥ 65 years: impact on recurrence and survival.
Borderline ovarian tumor (BOT) is uncommon in women with advanced age. The authors investigated the characteristics and treatment outcomes of women wi...